MedinCell S.A.
MDCLF · OTC
3/31/2025 | 9/30/2024 | 3/31/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $188 | $182 | $188 | $184 |
| - Cash | $59 | $32 | $19 | $12 |
| + Debt | $59 | $60 | $59 | $63 |
| Enterprise Value | $187 | $210 | $227 | $235 |
| Revenue | – | $9 | $4 | $7 |
| % Growth | – | 150.6% | -46.1% | – |
| Gross Profit | – | $9 | $3 | $4 |
| % Margin | – | 100% | 91.3% | 58.6% |
| EBITDA | – | -$7 | -$12 | -$4 |
| % Margin | – | -76.9% | -306.8% | -51.7% |
| Net Income | – | -$15 | -$17 | -$8 |
| % Margin | – | -154.4% | -448.3% | -116.8% |
| EPS Diluted | – | -0.5 | -0.58 | -0.29 |
| % Growth | – | 13.8% | -100% | – |
| Operating Cash Flow | – | $22 | -$0 | -$13 |
| Capital Expenditures | – | -$0 | -$0 | -$0 |
| Free Cash Flow | – | $21 | -$0 | -$14 |